365 related articles for article (PubMed ID: 32289501)
61. Enzymatic cleavage promotes disassembly of GII.3 norovirus virus like particles and its binding to salivary histo-blood group antigens.
Huo Y; Wang W; Zheng L; Chen X; Shen S; Wang M
Virus Res; 2017 Aug; 240():18-24. PubMed ID: 28754559
[TBL] [Abstract][Full Text] [Related]
62. GII.P16-GII.2 Recombinant Norovirus VLPs Polarize Macrophages Into the M1 Phenotype for Th1 Immune Responses.
Han JC; Li QX; Fang JB; Zhang JY; Li YQ; Li SZ; Cheng C; Xie CZ; Nan FL; Zhang H; Li ZX; Jin NY; Zhu GZ; Lu HJ
Front Immunol; 2021; 12():781718. PubMed ID: 34868056
[TBL] [Abstract][Full Text] [Related]
63. Receptor profile and immunogenicity of the non-epidemic norovirus GII.8 variant.
Gao J; Xue L; Liang Y; Wang L; He F; Meng L; Cai W; Zhang J; Wang J; Ye Q; Wu S; Gu Q; Wu Q
Virus Res; 2021 Dec; 306():198603. PubMed ID: 34662679
[TBL] [Abstract][Full Text] [Related]
64. Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope.
Lindesmith LC; Donaldson EF; Beltramello M; Pintus S; Corti D; Swanstrom J; Debbink K; Jones TA; Lanzavecchia A; Baric RS
J Virol; 2014 Aug; 88(16):8826-42. PubMed ID: 24872579
[TBL] [Abstract][Full Text] [Related]
65. Expression and characterization of the major capsid protein derived from a GII.6 norovirus strain isolated in China.
Huo Y; Zheng L; Chen X; Ge L; Wang Y
Microb Pathog; 2017 Apr; 105():131-137. PubMed ID: 28219831
[TBL] [Abstract][Full Text] [Related]
66. Linear epitope binding antibodies against GII.3 Norovirus exhibit no histo-blood group antigens (HBGAs) blocking effects.
Ma S; Zhang F; Zheng L; Liu J; Ma J; Chen X; Yang Z; Wang W; Li L; Wang M; Huo Y
Virus Genes; 2019 Jun; 55(3):280-289. PubMed ID: 30725444
[TBL] [Abstract][Full Text] [Related]
67. Genetic Susceptibility to Norovirus GII.4 Sydney Strain Infections in Taiwanese Children.
Tu LT; Liu FP; Huang YC; Huang CG; Yang S; Tsao KC; Lai MW; Chen CJ
Pediatr Infect Dis J; 2017 Apr; 36(4):353-357. PubMed ID: 27918380
[TBL] [Abstract][Full Text] [Related]
68. Characterization of a hospital-based gastroenteritis outbreak caused by GII.6 norovirus in Jinshan, China.
Zhang XF; Chen JR; Song CL; Xie DJ; Tan M; Wang L; Koroma MM; Hou YZ; Dong ZP; Yu JR; Duan WT; Zhao DD; Du JR; Zhu L; Dai YC
Epidemiol Infect; 2020 Dec; 148():e289. PubMed ID: 33292874
[TBL] [Abstract][Full Text] [Related]
69. Association of histo-blood group antigens and susceptibility to norovirus infections.
Rockx BH; Vennema H; Hoebe CJ; Duizer E; Koopmans MP
J Infect Dis; 2005 Mar; 191(5):749-54. PubMed ID: 15688291
[TBL] [Abstract][Full Text] [Related]
70. Genotype distribution of norovirus around the emergence of Sydney_2012 and the antigenic drift of contemporary GII.4 epidemic strains.
Zhang J; Shen Z; Zhu Z; Zhang W; Chen H; Qian F; Chen H; Wang G; Wang M; Hu Y; Yuan Z
J Clin Virol; 2015 Nov; 72():95-101. PubMed ID: 26476326
[TBL] [Abstract][Full Text] [Related]
71. Norovirus GII.4 strain antigenic variation.
Lindesmith LC; Donaldson EF; Baric RS
J Virol; 2011 Jan; 85(1):231-42. PubMed ID: 20980508
[TBL] [Abstract][Full Text] [Related]
72. Characterization of blockade antibody responses in GII.2.1976 Snow Mountain virus-infected subjects.
Swanstrom J; Lindesmith LC; Donaldson EF; Yount B; Baric RS
J Virol; 2014 Jan; 88(2):829-37. PubMed ID: 24173225
[TBL] [Abstract][Full Text] [Related]
73. Secretor Status Strongly Influences the Incidence of Symptomatic Norovirus Infection in a Genotype-Dependent Manner in a Nicaraguan Birth Cohort.
Reyes Y; González F; Gutiérrez L; Blandón P; Centeno E; Zepeda O; Toval-Ruíz C; Lindesmith LC; Baric RS; Vielot N; Diez-Valcarce M; Vinjé J; Svensson L; Becker-Dreps S; Nordgren J; Bucardo F
J Infect Dis; 2022 Jan; 225(1):105-115. PubMed ID: 34129046
[TBL] [Abstract][Full Text] [Related]
74. Characterization of the new GII.17 norovirus variant that emerged recently as the predominant strain in China.
Jin M; Zhou YK; Xie HP; Fu JG; He YQ; Zhang S; Jing HB; Kong XY; Sun XM; Li HY; Zhang Q; Li K; Zhang YJ; Zhou DQ; Xing WJ; Liao QH; Liu N; Yu HJ; Jiang X; Tan M; Duan ZJ
J Gen Virol; 2016 Oct; 97(10):2620-2632. PubMed ID: 27543110
[TBL] [Abstract][Full Text] [Related]
75. Use of rabbit antibodies raised against
Kulkarni R; Lole K; Chitambar SD
Indian J Med Res; 2017 Dec; 146(6):788-790. PubMed ID: 29664039
[No Abstract] [Full Text] [Related]
76. Norovirus immunity and the great escape.
Debbink K; Lindesmith LC; Donaldson EF; Baric RS
PLoS Pathog; 2012; 8(10):e1002921. PubMed ID: 23093932
[No Abstract] [Full Text] [Related]
77. Structural analysis of determinants of histo-blood group antigen binding specificity in genogroup I noroviruses.
Shanker S; Czako R; Sankaran B; Atmar RL; Estes MK; Prasad BV
J Virol; 2014 Jun; 88(11):6168-80. PubMed ID: 24648450
[TBL] [Abstract][Full Text] [Related]
78. Norovirus-host interaction: multi-selections by human histo-blood group antigens.
Tan M; Jiang X
Trends Microbiol; 2011 Aug; 19(8):382-8. PubMed ID: 21705222
[TBL] [Abstract][Full Text] [Related]
79. Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 protein.
Malm M; Tamminen K; Vesikari T; Blazevic V
Mol Immunol; 2016 Oct; 78():27-37. PubMed ID: 27573255
[TBL] [Abstract][Full Text] [Related]
80. Pre-existing immunity to norovirus GII-4 virus-like particles does not impair de novo immune responses to norovirus GII-12 genotype.
Tamminen K; Huhti L; Vesikari T; Blazevic V
Viral Immunol; 2013 Apr; 26(2):167-70. PubMed ID: 23438469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
